• 1
    WHO. Public health impact of schistosomiasis: disease and mortality. Bull World Health Organ 1993; 71: 65762.
  • 2
    Ibrahim S. Site distribution of cancer in Egypt: twelve years experience (1970–1981). In: GjorgoveA,IsmailA, eds. Cancer prevention in developing countries. Oxford: Pergamon Press, 1986. 4550.
  • 3
    Zhang R,Takahashi S,Orita S,Yoshida A,Maruyama H,Shirai T,Ohta N. p53 gene mutations in rectal cancer associated with schistosomiasis japonica in Chinese patients. Cancer Lett 1998; 131: 21521.
  • 4
    Madbouly KM,Senagore AJ,Mukerjee A,Hussien AM,Shehata MA,Navine P,Delaney CP,Fazio VW. Colorectal cancer in a population with endemic Schistosoma mansoni: is this an at-risk population? Int J Colorectal Dis 2007; 22: 17581.
  • 5
    WHO/IARC.IARC monographs on the evaluation of carcinogenic risk to humans. Schistosomas, liver flukes and helicobacter pylori. Summary of data reported and evaluation. vol. 61. Lyon, France: IARC, 1994.
  • 6
    Fukushima S,Asamoto M,Imaida K,El-Bolkainy MN,Tawfik HN,Ito N. Comparative study of urinary bladder carcinomas in Japanese and Egyptians. Acta Pathol Jpn 1989; 39: 1769.
  • 7
    Chaudhary KS,Lu QL,Abel PD,Khandan-Nia N,Shoma AM,el Baz M,Stamp GW,Lalani EN. Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder. Br J Urol 1997; 79: 7884.
  • 8
    Muscheck M,Abol-Enein H,Chew K,Moore D,II,Bhargava V,Ghoneim MA,Carroll PR,Waldman FM. Comparison of genetic changes in schistosoma-related transitional and squamous bladder cancers using comparative genomic hybridization. Carcinogenesis 2000; 21: 17216.
  • 9
    Badawi AF. Molecular and genetic events in schistosomiasis-associated human bladder cancer: role of oncogenes and tumor suppressor genes. Cancer Lett 1996; 105: 12338.
  • 10
    Mostafa MH,Helmi S,Badawi AF,Tricker AR,Spiegelhalder B,Preussmann R. Nitrate, nitrite and volatile N-nitroso compounds in the urine of schistosoma hematobium and schistosoma mansoni infected patients. Carcinogenesis 1994; 4: 61925.
  • 11
    Gentile JM,Gentile GJ. Implications for the involvement of the immune system in parasite-associated cancers. Mutat Res 1994; 305: 31520.
  • 12
    Wu R-L,Osman I,Wu X-R,Lu M-L,Zhang Z-F,Liang F-X,Hamza R,Scher H,Cordon-Cardo C,Sun T-T. Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation. Cancer Res 1998; 58: 12917.
  • 13
    Hanahan D,Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 5770.
  • 14
    Cadet J,Bourdat AG,D'Ham C,Duarte V,Gasparutto D,Romieu A,Ravanat JL. Oxidative base damage to DNA: specificity of base excision repair enzymes. Mutat Res 2000; 462: 1218.
  • 15
    Frosina G. Overexpression of enzymes that repair endogenous damage to DNA. Eur J Biochem 2000; 267: 213549.
  • 16
    Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82: 4795.
  • 17
    Tubiana M. The report of the french academy of science. Problems associated with the effects of low doses of ionizing radiation. J Radiol Prot 1998; 18: 24348.
  • 18
    Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000; 21: 36170.
  • 19
    Wilson KT,Fu S,Ramanujam KS,Meltzer SJ. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res 1998; 58: 292934.
  • 20
    Nakae D,Kobayashi Y,Akai H,Andoh N,Satoh H,Ohashi K,Tsutsumi M,Konishi Y. Involvement of 8-hydroxuguanine formation in the initiation of rat liver carcinogenesis by low dose levels of N-nitrosodiethylamine. Cancer Res 1997; 57: 12817.
  • 21
    Shibutani S,Takeshita M,Grollman AP. Insertion of specific base during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 1991; 349: 4314.
  • 22
    Mitra S,Boldogh I,Izumi T,Hazra TK. Complexities of the DNA base excision repair pathway for repair of oxidative DNA damage. Environ Mol Mutagen 2001; 38: 18090.
  • 23
    Ramana CV,Boldogh I,Izumi T,Mitra S. Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals. Proc Natl Acad Sci USA 1998; 95: 50616.
  • 24
    Takao M,Aburatani H,Kobayashi K,Yasui A. Mitochondrial targeting of human DNA glycosylases for repair of oxidative DNA damage. Nucleic Acids Res 1998; 26: 291722.
  • 25
    McCullough AK,Dodson ML,Lloyd RS. Initiation of base excision repair: glycosylase mechanisms and structures. Annu Rev Biochem 1999; 68: 25585.
  • 26
    Braithwaite E,Wu X,Wang Z. Repair of DNA lesions induced by polycyclic aromatic hydrocarbons in human cell-free extracts: involvement of two excision repair mechanisms in vitro. Carcinogenesis 1998; 19: 123946.
  • 27
    Herring CJ,West CM,Wilks DP,Davidson SE,Hunter RD,Berry P,Forster G,MacKinnon J,Rafferty JA,Elder RH,Hendry JH,Margison GP. Levels of the DNA repair enzyme human apurinic/apyrimidinic endonuclease (APE-1, APEX, Ref-1) are associated with the intrinsic radiosensitivity of cervical cancers. Br J Cancer 1998; 78: 112833.
  • 28
    Naruse I,Keino H,Kawarada Y. Antibody against single-stranded DNA detects both programmed cell death and drug-induced apoptosis. Histochemistry 1994; 7: 184951.
  • 29
    Ohshima H,Tatemichi M,Sawa T. Chemical basis of inflammation-induced carcinogenesis. Arch Biochem Biophys 2003; 417: 311.
  • 30
    Glassner BJ,Rasmussen LJ,Najarian MT,Posnick LM,Samson LD. Generation of a strong mutator phenotype in yeast by imbalanced base excision repair. Proc Natl Acad Sci USA 1998; 95: 999710002.
  • 31
    Schar P. Spontaneous DNA damage, genome instability, and cancer: when DNA replication escapes control. Cell 2001; 104: 32932.
  • 32
    Le Page F,Randrianarison V,Marot D,Cabannes J,Perricaudet M,Feunteun J,Sarasin A. BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells. Cancer Res 2000; 60: 554852.
  • 33
    Le Page F,Schreiber V,Dhe'rin C,De Murcia G,Boiteux S. Poly (ADP-ribose) polymerase-1 (PARP-1) is required in murine cell lines for base excision repair of oxidative DNA damage in the absence of DNA Polymerase β. J Biol Chem 2003; 278: 184717.
  • 34
    Marsin S,Vidal AE,Sossou M,Me'nissier-de Murcia J,Le Page F,Boiteux S,de Murcia G,Radicella JP. Role of XRCC1 in the coordination and stimulation of oxidative DNA damage repair initiated by the DNA glycosylase hOGG1. J Biol Chem 2003; 278: 4406874.
  • 35
    Palmer RMJ,Ferrige AG,Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 52426.
  • 36
    Bredt DS,Snyder SH. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 1994; 63: 17595.
  • 37
    Griffith OW,Stuehr DJ. Nitric oxide synthases: properties and catalytic mechanism. Annu Rev Physiol 1995; 57: 70736.
  • 38
    MostofiFK,DavisC,SesterhennJ, eds. Histological typing of urinary bladder tumors. International histological classification of tumors,2nd edn. Heidelberg, Berlin: Springer Verlag, 1999.
  • 39
    SobinLH,FlemingID, eds. TNM classification of malignant tumors,5th edn. New York: Wiley-Liss, 1997. 18034.
  • 40
    Malmstrom PU,Busch C,Norlen BJ,Andersson B. Expression of ABH blood group isoantigen as a prognostic factor in transitional cell bladder carcinoma. Scand J Urol Nephrol 1988; 22: 26570.
  • 41
    Parsons JL,Dianova IL,Dianov GL. APE-1 dependent repair of DNA single strand breaks containing 3′-end 8-oxoguanine. Nucleic Acids Res 2005; 33: 22049.
  • 42
    Romanenko A,Morimura K,Wei M,Zaparin W,Vozianov A,Fukushima S. DNA damage and repair in bladder urothelium after the Chernobyl accident in Ukraine. J Urol 2002; 168: 9737.
  • 43
    Ohshima H,Sawa T,Akaike T. Nitroguanine, a product of nitrative DNA damage caused by reactive nitrogen species: formation, occurrence, and implications in inflammation and carcinogenesis. Antioxid Redox Signal 2006; 8: 103345.
  • 44
    Warren W,Biggs PJ,el-Baz M,Ghoneim MA,Stratton MR,Venitt S. Mutations in p53 gene in Schistosomal bladder cancer: a study of 92 tumors from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours. Carcinogenesis 1995; 16: 11819.
  • 45
    Inoue S,Kawanishi S. Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide. FEBS Lett 1995; 371: 868.
  • 46
    Epe B,Ballmaier D,Roussyn I,Briviba K,Sies H. DNA damage by peroxynitrite characterized with DNA repair enzymes. Nucleic Acids Res 1996; 24: 410510.
  • 47
    Bruner SD,Norman DP,Verdine GL. Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA. Nature 2000; 403: 85966.
  • 48
    Shochina M,Fellig Y,Sughayer M,Pizov G,Vitner K,Podeh D,Hochberg A,Ariel I. Nitric oxide synthase immunoreactivity in human bladder carcinoma. J Clin Pathol Mol Pathol 2001; 54: 24852.
  • 49
    Gentile JM,Brown S,Aardema M,Clark D,Blankespoor H. Modified mutagen metabolism in schistosoma hematobium-infested organisms. Arch Environ Health 1985; 40: 512.
  • 50
    Bahar G,Feinmesser R,Shpitzer T,Popovtzer A,Nagler RM. Salivary analysis in oral cancer patients: DNA and protein oxidation, reactive nitrogen species, and antioxidant profile. Cancer 2007; 109: 549.
  • 51
    Badawi AF,Cooper DP,Mostafa MH,Doenhoff MJ,Probert A,Fallon P,Cooper R,O'Connor PJ. Promutagenic methylation damage in liver DNA of mice infected with schistosoma mansoni. Carcinogenesis 1993; 14: 6537.
  • 52
    Okazaki K,Ishii Y,Kitamura Y,Maruyama S,Umemura Y,Miyauchi M,Yamagishi M,Imazawa K,Nishikawa A,Yoshimura Y,Nakazawa H,Hirose M. Dose-dependent promotion of rat forestomach carcinogenesis by combined treatment with sodium nitrite and ascorbic acid after initiating with N-methyl-N′-nitro-N-nitrosoguanidine: possible contribution of nitric oxide associated oxidative DNA damage. Cancer Sci 2006; 97: 17582.
  • 53
    Gutierrez MI,Siraj AK,Khaled H,Koon N,El-Refai W,Bhatia K. CpG island methylation in Schistosoma- and non-Schistosoma-associated bladder cancer. Mod Pathol 2004; 17: 126874.
  • 54
    Badawi AF,Cooper DP,Mostafa MH,Aboul-Azm T,Barnard R,Margison GP,O'Connor PJ. O6-alkylguanine-DNA alkyltransferase activity in schistosomiasis-associated human bladder cancer. Eur J Cancer 1994; 30: 131419.
  • 55
    Saad AA,O'Connor PJ,Mostafa MH,Metwalli NE,Cooper DP,Margison GP,Povey AC. Bladder tumor contains higher N7-methylguanine levels in DNA than adjacent normal bladder epithelium. Cancer Epidemiol Biomarkers Prev 2006; 15: 7403.
  • 56
    Gyorffy E,Anna L,Gyori Z,Segesdi J,Minárovits J,Soltész I,Kostic S,Csekeo A,Poirier MC,Schoket B. DNA adducts in tumor, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay. Carcinogenesis 2004; 25: 12019.
  • 57
    Catto JW,Xinarianos G,Burton JL,Meuth M,Hamdy FC. Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage andprognosis but not microsatellite instability. Int J Cancer 2003; 105: 48490.
  • 58
    Souliotis VL,Kaila S,Boussiotis VA,Pangalis GA,Kyrtopoulos SA. Accumulation of O6-methylguanine in human blood leukocyte DNA during exposure to procarbazine and its relationships with dose and repair. Cancer Res 1990; 50: 275964.
  • 59
    Lee SM,Margison GP,Thatcher N,O'Connor PJ,Cooper DP. Formation and loss of O6-methyldeoxyguanosine in human leucocyte DNA following sequential DTIC andfotemustine chemotherapy. Br J Cancer 1994; 69: 8537.
  • 60
    Yosry A. Schistosomiasis and neoplasia. Contrib Microbiol 2006; 13: 81100.
  • 61
    Sen CK,Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 1996; 10: 70920.
  • 62
    Slaga TJ. Overview of tumor promotion in animals. Environ Health Perspect 1983; 50: 314.
  • 63
    Hussain SP,Amstad P,Raja K,Ambs S,Nagashima M,Bennett WP,Shields PG,Ham AJ,Swenberg JA,Marrogi AJ,Harris CC. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res 2000; 60: 33337.